rs770857110

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_006517.5(SLC16A2):​c.-109C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000591 in 1,015,519 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000033 ( 0 hom. 0 hem. )

Consequence

SLC16A2
NM_006517.5 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.207

Publications

0 publications found
Variant links:
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
SLC16A2 Gene-Disease associations (from GenCC):
  • Allan-Herndon-Dudley syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.024).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006517.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC16A2
NM_006517.5
MANE Select
c.-109C>A
5_prime_UTR
Exon 1 of 6NP_006508.2P36021

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC16A2
ENST00000587091.6
TSL:1 MANE Select
c.-109C>A
5_prime_UTR
Exon 1 of 6ENSP00000465734.1P36021
SLC16A2
ENST00000878592.1
c.-109C>A
5_prime_UTR
Exon 1 of 7ENSP00000548651.1
SLC16A2
ENST00000922847.1
c.-109C>A
5_prime_UTR
Exon 1 of 7ENSP00000592906.1

Frequencies

GnomAD3 genomes
AF:
0.0000269
AC:
3
AN:
111581
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000187
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000667
GnomAD2 exomes
AF:
0.00000843
AC:
1
AN:
118650
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000133
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000332
AC:
3
AN:
903938
Hom.:
0
Cov.:
17
AF XY:
0.00
AC XY:
0
AN XY:
255120
show subpopulations
African (AFR)
AF:
0.0000444
AC:
1
AN:
22522
American (AMR)
AF:
0.00
AC:
0
AN:
28829
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27272
South Asian (SAS)
AF:
0.00
AC:
0
AN:
47427
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35591
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3134
European-Non Finnish (NFE)
AF:
0.00000147
AC:
1
AN:
681977
Other (OTH)
AF:
0.0000253
AC:
1
AN:
39534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000269
AC:
3
AN:
111581
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33813
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30701
American (AMR)
AF:
0.000187
AC:
2
AN:
10684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2637
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3496
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2634
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6089
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52920
Other (OTH)
AF:
0.000667
AC:
1
AN:
1499
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000102

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
7.0
DANN
Benign
0.97
PhyloP100
-0.21
PromoterAI
0.026
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770857110; hg19: chrX-73641364; API